MTSS1 (also termed MIM for “missing in metastasis”) had initially been identified as a gene that was downregulated in cell lines from metastatic bladder, prostate, and breast cancer as compared to cell lines from patients with non-metastatic malignancies [23]. The gene discussed is MTSS1; the disease is breast cancer.